- Home
- SPH vs ATRC Comparison
SPH vs ATRC Comparison
Compare SPH & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPH
- ATRC
- Stock Information
- Founded
- SPH 1945
- ATRC 2000
- Country
- SPH United States
- ATRC United States
- Employees
- SPH N/A
- ATRC N/A
- Industry
- SPH Other Specialty Stores
- ATRC Medical/Dental Instruments
- Sector
- SPH Consumer Discretionary
- ATRC Health Care
- Exchange
- SPH Nasdaq
- ATRC Nasdaq
- Market Cap
- SPH 1.2B
- ATRC 1.6B
- IPO Year
- SPH 1996
- ATRC 2005
- Fundamental
- Price
- SPH $18.56
- ATRC $32.14
- Analyst Decision
- SPH Sell
- ATRC Strong Buy
- Analyst Count
- SPH 1
- ATRC 10
- Target Price
- SPH $17.00
- ATRC $49.60
- AVG Volume (30 Days)
- SPH 211.0K
- ATRC 458.8K
- Earning Date
- SPH 08-07-2025
- ATRC 07-29-2025
- Dividend Yield
- SPH 7.05%
- ATRC N/A
- EPS Growth
- SPH N/A
- ATRC N/A
- EPS
- SPH 1.46
- ATRC N/A
- Revenue
- SPH $1,424,243,000.00
- ATRC $480,076,000.00
- Revenue This Year
- SPH $10.99
- ATRC $14.63
- Revenue Next Year
- SPH N/A
- ATRC $12.62
- P/E Ratio
- SPH $12.63
- ATRC N/A
- Revenue Growth
- SPH 4.02
- ATRC 15.79
- 52 Week Low
- SPH $15.20
- ATRC $20.20
- 52 Week High
- SPH $22.24
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- SPH 47.76
- ATRC 47.04
- Support Level
- SPH $18.00
- ATRC $30.98
- Resistance Level
- SPH $19.40
- ATRC $33.00
- Average True Range (ATR)
- SPH 0.53
- ATRC 1.12
- MACD
- SPH 0.06
- ATRC -0.08
- Stochastic Oscillator
- SPH 56.50
- ATRC 30.52
About SPH Suburban Propane Partners L.P.
Suburban Propane Partners LP distributes propane, fuel oil, and other refined fuels to customers in the East Coast and West Coast regions of the United States. Other operations include natural gas and electricity marketing in the deregulated New York and Pennsylvania markets. The company operates in three segments: Propane; Fuel Oil and Refined Fuels; and Natural Gas and Electricity. It generates maximum revenue from Propane segment.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.